Earnings Feed
Start Free
Pelthos Therapeutics Inc.·4/A

Apr 1, 5:45 PM ET

Friedberg Ezra M 4/A

Research Summary

AI-generated summary

Updated

Pelthos (PTHS) Director Ezra Friedberg Receives RSU Awards

What Happened

  • Ezra M. Friedberg, a director of Pelthos Therapeutics Inc. (PTHS), received restricted stock unit (RSU) awards (compensation grants) on three dates. The grants reported are: 6,450 RSUs (6/14/2024), 2,454 RSUs (11/13/2024), and 19,108 RSUs (7/02/2025), totaling 28,012 RSUs. Each award was reported at $0.00 purchase price (awarded as compensation). This filing is an AMENDED Form 4 that reformats prior reporting (see footnotes).

Key Details

  • Transaction dates and amounts:
    • 2024-06-14 — 6,450 RSUs @ $0.00
    • 2024-11-13 — 2,454 RSUs @ $0.00
    • 2025-07-02 — 19,108 RSUs @ $0.00
  • Total RSUs granted (sum): 28,012 RSUs (amounts adjusted for a 1-for-10 reverse split per footnote).
  • Shares owned after transaction: not specified in this amendment (filing reports the grants; check company filings for current beneficial ownership).
  • Notable footnotes:
    • F1: This amendment moves previously reported RSU grants into Table I; original Form 4s for these grants were filed between June 18, 2024 and July 7, 2025.
    • F2: RSUs were awarded as board compensation and vest in equal quarterly installments over three years, conditioned on continued service.
    • F3: Reported amounts reflect a 1-for-10 reverse stock split on July 1, 2025.
    • F4: Mr. Friedberg is manager of Balmoral Financial Group LLC and Key Recovery Group LLC; he disclaims beneficial ownership of shares held by those entities except for any pecuniary interest.
  • Filing timeliness: This is an amended filing (filed 2026-04-01) that restates earlier Form 4 reporting; consult the original filings for the initial reporting dates and timeliness.

Context

  • RSUs are compensation awards that convert into shares according to vesting terms; these awards were not purchases and involved no cash outlay at grant. The awards vest quarterly over three years and may be settled solely in Pelthos common stock when vested.
  • Awards to directors are common as part of board compensation and do not by themselves indicate buying or selling intent. For a full picture of insider interest, compare these grants to subsequent vesting, any sales, and overall insider holdings.